After CRISPR/Cas9 reduced the expression level of PD-L1 on tumor cells, CD4 T cells, CD8 T cells, NK cells and CD11c M1 macrophages increased significantly in the tumor microenvironment, while regulatory T cells decreased. This evidence concerns the gene ITGAX and neoplasm.